<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Sodium Valproate: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int987-sodium-valproate.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="bnf_int987-sodium-valproate.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int987-sodium-valproate.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int276-antiepileptics.htm">Antiepileptics</a> &gt; <a href="bnf_int286-valproate.htm">Valproate</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int286-valproate.htm" title="Previous: Valproate">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int287-vigabatrin.htm" title="Next: Vigabatrin">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Sodium Valproate</h1><?highlighter on?><div id="pC" class="jN"><p><strong>Sodium Valproate</strong> has no specific interaction information.</p><div class="cG"><p><strong>Note:</strong> Sodium valproate interactions as for valproate</p></div><p><strong>Sodium Valproate</strong> belongs to <strong>Valproate</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int361-aspirin.htm">Aspirin</a></td><td><p><span>effects of </span> <span>valproate</span> <span>enhanced by</span> <span>aspirin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int896-bupropion.htm">Bupropion</a></td><td><p><span></span> <span>valproate</span> <span>inhibits the metabolism of</span> <span>bupropion</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td><p><span>plasma concentration of </span> <span>valproate</span> <span>reduced by</span> <span>carbamazepine</span> <span>, also plasma concentration of active metabolite of <span>carbamazepine</span> increased</span>  </p></td><td></td></tr><tr><td><a href="bnf_int138-carbapenems.htm">Carbapenems</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>valproate</span> <span>reduced by</span> <span>carbapenems</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int744-cimetidine.htm">Cimetidine</a></td><td class="cAI"><p><span>metabolism of </span> <span>valproate</span> <span>inhibited by</span> <span>cimetidine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int409-clobazam.htm">Clobazam</a></td><td><p><span>plasma concentration of </span> <span>valproate</span> <span>possibly increased by</span> <span>clobazam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int408-clonazepam.htm">Clonazepam</a></td><td><p><span>increased risk of side-effects when </span> <span>valproate</span> <span>given with</span> <span>clonazepam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int364-clozapine.htm">Clozapine</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases or decreases plasma concentration of</span> <span>clozapine</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Avoid concomitant use of clozapine with drugs that have a substantial potential for causing agranulocytosis</p></div></td></tr><tr><td><a href="bnf_int592-colestyramine.htm">Colestyramine</a></td><td><p><span>absorption of </span> <span>valproate</span> <span>possibly reduced by</span> <span>colestyramine</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Other drugs should be taken at least 1 hour before or 4–6 hours after colestyramine to reduce possible interference with absorption</p></div></td></tr><tr><td><a href="bnf_int220-coumarins.htm">Coumarins</a></td><td><p><span></span> <span>valproate</span> <span>possibly enhances anticoagulant effect of</span> <span>coumarins</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div></td></tr><tr><td><a href="bnf_int412-diazepam.htm">Diazepam</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>diazepam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td><p><span>metabolism of </span> <span>valproate</span> <span>possibly inhibited by</span> <span>erythromycin</span> <span>(increased plasma concentration)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int638-ethinylestradiol.htm">Ethinylestradiol</a></td><td><p><span>plasma concentration of </span> <span>valproate</span> <span>possibly reduced by</span> <span>ethinylestradiol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int281-ethosuximide.htm">Ethosuximide</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>ethosuximide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int283-lamotrigine.htm">Lamotrigine</a></td><td class="cAI"><p><span></span> <span>valproate</span> <span>increases plasma concentration of</span> <span>lamotrigine</span> <span>(increased risk of toxicity—reduce <span>lamotrigine</span> dose)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int413-lorazepam.htm">Lorazepam</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>lorazepam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int366-olanzapine.htm">Olanzapine</a></td><td class="cAI"><p><span>increased risk of side-effects including neutropenia when </span> <span>valproate</span> <span>given with</span> <span>olanzapine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int900-oxcarbazepine.htm">Oxcarbazepine</a></td><td><p><span></span> <span>valproate</span> <span>sometimes reduces plasma concentration of an active metabolite of</span> <span>oxcarbazepine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int437-phenobarbital.htm">Phenobarbital</a></td><td><p><span></span> <span>valproate</span> <span>increases plasma concentration of</span> <span>phenobarbital</span> <span>(also plasma concentration of <span>valproate</span> reduced)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td><p><span></span> <span>valproate</span> <span>increases or possibly decreases plasma concentration of</span> <span>phenytoin</span> <span>, also plasma concentration of <span>valproate</span> reduced</span>  </p></td><td></td></tr><tr><td><a href="bnf_int893-pivmecillinam.htm">Pivmecillinam</a></td><td class="cAI"><p><span>avoidance of </span> <span>valproate</span> <span>advised by manufacturer of</span> <span>pivmecillinam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int824-quetiapine.htm">Quetiapine</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>quetiapine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1102-rufinamide.htm">Rufinamide</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>rufinamide</span> <span>(reduce dose of <span>rufinamide</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1034-sodium-benzoate.htm">Sodium Benzoate</a></td><td><p><span></span> <span>valproate</span> <span>possibly reduces effects of</span> <span>sodium benzoate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1033-sodium-phenylbutyrate.htm">Sodium Phenylbutyrate</a></td><td><p><span></span> <span>valproate</span> <span>possibly reduces effects of</span> <span>sodium phenylbutyrate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int885-temozolomide.htm">Temozolomide</a></td><td><p><span></span> <span>valproate</span> <span>increases plasma concentration of</span> <span>temozolomide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int285-topiramate.htm">Topiramate</a></td><td><p><span>hyperammonaemia and CNS toxicity reported when </span> <span>valproate</span> <span>given with</span> <span>topiramate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int403-zidovudine.htm">Zidovudine</a></td><td><p><span></span> <span>valproate</span> <span>possibly increases plasma concentration of</span> <span>zidovudine</span> <span>(increased risk of toxicity)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Increased risk of toxicity with nephrotoxic and myelosuppressive drugs—for further details consult product literature</p></div></td></tr></tbody></table><p><strong>Sodium Valproate</strong> belongs to <strong>Antiepileptics</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int232-antidepressants-ssri.htm">Antidepressants, SSRI</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>SSRIs</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>tricyclics</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int252-antidepressants-tricyclic-related.htm">Antidepressants, Tricyclic (related)</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>possibly antagonised by</span> <span>tricyclic-related antidepressants</span> <span>(convulsive threshold lowered)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int363-antipsychotics.htm">Antipsychotics</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>antipsychotics</span> <span>(convulsive threshold lowered)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Increased risk of toxicity with myelosuppressive drugs</p></div></td></tr><tr><td><a href="bnf_int257-maois.htm">MAOIs</a></td><td><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>possibly antagonised by</span> <span>MAOIs</span> <span>(convulsive threshold lowered)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> For interactions of reversible MAO-A inhibitors (RIMAs) see Moclobemide, and for interactions of MAO-B inhibitors see Rasagiline and Selegiline; the antibacterial Linezolid is a reversible, non-selective MAO inhibitor</p></div></td></tr><tr><td><a href="bnf_int337-mefloquine.htm">Mefloquine</a></td><td class="cAI"><p><span>anticonvulsant effect of </span> <span>antiepileptics</span> <span>antagonised by</span> <span>mefloquine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int856-orlistat.htm">Orlistat</a></td><td class="cAI"><p><span>possible increased risk of convulsions when </span> <span>antiepileptics</span> <span>given with</span> <span>orlistat</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int905-st-johns-wort.htm">St John's Wort</a></td><td class="cAI"><p><span>avoid concomitant use of </span> <span>antiepileptics</span> <span>with</span> <span>St John's wort</span> <span></span>  </p></td><td></td></tr></tbody></table></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int286-valproate.htm">Previous: Valproate</a> | <a class="top" href="bnf_int987-sodium-valproate.htm#">Top</a> | <a accesskey="]" href="bnf_int287-vigabatrin.htm">Next: Vigabatrin</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>